Skip to content

The effect of fennel(Foeniculum Vulgar) oral capsules on menopausal symptoms

The effect of fennel (Foeniculum Vulgar) oral capsules on menopausal symptoms in postmenopausal women: Triple blind randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016050827788N1
Enrollment
90
Registered
2016-05-26
Start date
2016-04-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

menopausal symptoms. Menopausal and female climacteric states

Interventions

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women aged between 45-60 years; married women; women in the first 1-5 years of their post menopausal period; achieving a minimum score of 9 by women according to Menopause Rating Scale questionnaire ( middle severity of menopausal symptoms); Negative history of physical and psychological diseases; Negative history of hormone therapy and complementary medicine for menopausel symptoms; Negative history of Allergy to herbal medicine; Negative history of sedative and anti depressant drugs usage; Negative history of addiction and smoking; women with at least the ability to read and write. exclusion criteria: allergy to foeniculum vulgare during the intervention; worsening the disease during the intervention; poor cooperation during the intervention; stop using foeniculum vulgare/placebo for at least 6 days; using of other remedies for menopausal symptoms during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity score of Menopausal Symptoms. Timepoint: Before intervention, at the end of 4th, 8th and 10th week of intervention. Method of measurement: Menopause Rating Scale questionnaire.

Secondary

MeasureTime frame
Severity score of physical symptoms, Severity score of psychological symptoms, Severity score of urogenital symptoms. Timepoint: Before intervention, at the end of 4th, 8th and 10th week of intervention. Method of measurement: MRS questionare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Golzareh

Nursing and Midwifery Faculty, Tehran University of Medical Sciences

golzareh23@yahoo.com+98 21 6105 4312

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026